Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program
Transplant Cell Ther. 2021 Mar;27(3):267.e1-267.e5. doi: 10.1016/j.jtct.2020.12.015.…
Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study
Bone Marrow Transplant. 2021 Aug;56(8):1919-1928. doi: 10.1038/s41409-021-01264-3.…
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial
J Clin Oncol. 2021 Jun 20;39(18):1959-1970. doi: 10.1200/JCO.20.03175.…
The direct and indirect effects of COVID-19 pandemic in a real-life hematological setting
Cancer Rep (Hoboken). 2021 Aug;4(4):e1358. doi: 10.1002/cnr2.1358.…
Isavuconazole prophylaxis against invasive fungal infections in allogeneic stem cell transplantation: A single-center experience
Hematol Transfus Cell Ther. 2022 Jul-Sep;44(3):440-443. doi:…
XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis
Blood Cancer J. 2021 Feb 1;11(2):27. doi: 10.1038/s41408-021-00409-3.NO…
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study
Hematol Oncol. 2021 Apr;39(2):185-195. doi: 10.1002/hon.2838.…
Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study
Lancet Oncol. 2021 Jan;22(1):142-154. doi: 10.1016/S1470-2045(20)30680-X.…
Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
BMC Cancer. 2020 Nov 10;20(1):1088. doi: 10.1186/s12885-020-07561-2.ABSTRACTAutologous…
Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality
Blood Cancer J. 2020 Oct 19;10(10):103. doi: 10.1038/s41408-020-00372-5.ABSTRACTThere…
Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMT
Bone Marrow Transplant. 2021 Mar;56(3):655-663. doi: 10.1038/s41409-020-01075-y.…
Impact of Reduced-Intensity Conditioning Regimens on Outcomes in Diffuse Large B Cell Lymphoma Undergoing Allogeneic Transplantation
Transplant Cell Ther. 2021 Jan;27(1):58-66. doi: 10.1016/j.bbmt.2020.09.014.…
